NCT07045857 Recurrence of H Pylori : Incidence and Influential Factors.
| NCT ID | NCT07045857 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | H. Pylori Infection |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-05-13 |
| Primary Completion | 2025-11-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-05-13 with a primary completion date of 2025-11-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to determine recurrence rates, identify influential factors, investigate key factors that contribute to recurrence, evaluate treatment effectiveness and to assess the efficacy of different eradication regimens and their role in reducing recurrence.
Eligibility Criteria
Inclusion Criteria: * Age: 18-75 years old. * H. pylori infection: Confirmed by endoscopy, biopsy, or non-invasive tests (e.g., urea breath test, stool antigen test). * Symptoms: Presence of dyspepsia, peptic ulcer disease, or other H. pylori-related symptoms. * Laboratory tests: Normal liver and kidney function, and no significant abnormalities in blood counts. Exclusion Criteria: * Patients receiving eradication therapy in the past taking proton pump inhibitors,, H2 blockers ,,bismuth ,, antibiotics or other medications that interfere with the result of the examination in the recent 4 weeks. * Gastrointestinal disorders: Severe gastrointestinal disorders (e.g., gastric cancer, inflammatory bowel disease ,gastric or duodenal ulcer with current or recent bleeding , or clinical significant gastrointestinal bleeding within 4 weeks of randomization). * Malignancies: Active or recent malignancies. * Severe comorbidities: Unstable or severe comorbidities (e.g., heart failure, liver cirrhosis).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07045857 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying H. Pylori Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07045857 currently recruiting?
Yes, NCT07045857 is actively recruiting participants. Contact the research team at thomaswagih0@gmail.com for enrollment information.
Where is the NCT07045857 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT07045857 clinical trial?
NCT07045857 is sponsored by Sohag University. The trial plans to enroll 100 participants.